Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAntipsychotic combinations: Blind step or logical
Current Psychiatry, 07/03/08
Gibson AP et al. - In a perfect world, every treatment decision would fall under the protective umbrella of evidence-based medicine. The reality is that up to 30% of schizophrenia patients respond poorly to antipsychotic monotherapy,1 and addressing their chronic debilitating illness requires clinicians to step outside the realm of evidence.
| Previous Article | Next Article |
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy
CNS Drugs, 06/15/09
Use of antipsychotics in neuropsychiatric symptoms of dementia
Geriatrics, 05/18/09
Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD
Pediatrics, 07/02/09
Article Search
Sponsor